Search
Clinical Trial
A Phase 1a/1b Study of 27T51, an anti-MUC16 CAR T cell drug product administered alone or in combination for participants with recurrent or refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( 27T51-01)
… primary peritoneal, or fallopian tube cancer ( 27T51-01) I Zsiros, Emese This study is researching an experimental CAR T …
Blog Post
Team Science Award to advance research on acute myeloid leukemia
… “Evaluating T-cells for Ovarian Cancer,” led by Emese Zsiros, MD, PhD, FACOG , Assistant Professor of Oncology in … Oncology and Center for Immunotherapy Of her project, Dr. Zsiros said, “Our project brings hope and innovation. With … “Evaluating T-cells for Ovarian Cancer,” led by Emese Zsiros, MD, PhD, FACOG , Assistant Professor of Oncology in …
Clinical Trial
Life on the Go 3: A Randomized Controlled Trial of Automated, Personalized Physical Activity Intervention Using Wearable Devices to Improve Immune Function and Clinical Outcomes in Ovarian and Endometrial Cancer Patients
… Outcomes in Ovarian and Endometrial Cancer Patients N/A Zsiros, Emese This clinical trial compares the effect of an …
Page with Layout
Clinical Trials for Uterine Cancer
… Sarcoma Skin Age Group - Any - Adult Pediatric Dr. Emese Zsiros explains some of the current clinical trials at …
Blog Post
Women in Science: Clinical research nurses
… Science: Pamela Hershberger, PhD Women in Science: Emese Zsiros MD, PhD Meet the Team Cancer Research & News …
Page with Layout
Clinical Trials for Ovarian Cancer
… Sarcoma Skin Age Group - Any - Adult Pediatric Dr. Emese Zsiros explains some of the current clinical trials at …
Education
Bi-Annual Gynecologic Cancer Seminar and the Retirement of Shashikant Lele, MD
… Leadership Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD Shashikant Lele, MD, Endowed Chair in … Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD Shashikant Lele, MD, Endowed Chair in …
Blog Post
Ovarian Cancer Patient Grateful for the Time Immunotherapy Has Given Her
… What a great feeling that was.” Falleti met with Emese Zsiros, MD, PhD , Department of Gynecologic Oncology. “After … followed by more chemotherapy. In February 2019, Dr. Zsiros told her the treatment wasn’t helping her. “That’s … What a great feeling that was.” Falleti met with Emese Zsiros, MD, PhD , Department of Gynecologic Oncology. “After …
Blog Post
Who should have high-risk cancer screenings?
… or have a family history of ovarian cancer, says Emese Zsiros, MD, PhD, FACOG , Chair of the Department of … a doctor and be genetically screened for mutations, Dr. Zsiros says. “Generally, this is done on a patient with … 30 until it is time for their risk-reducing surgery,” Dr. Zsiros says. “There are two screening tools currently …
Cancer Types
Why Roswell Park for Ovarian Cancer
… more than follow NCCN guidelines; they write them. Emese Zsiros, MD, PhD, FACOG , Chair of Gynecologic Oncology, sits … more than follow NCCN guidelines; they write them. Emese Zsiros, MD, PhD, FACOG , Chair of Gynecologic Oncology, sits …